GNE and prostate cancer: Although both CBPD-409 and GNE-049 triggered a similar decrease in overall abundance of H3K27ac histone modifications (Extended Data Fig. 5a), motif analyses revealed that CBPD-409 preferentially abolished the H3K27ac peaks at binding sites of prostate cancer-specific TFs (Fig. 3h).